Wigal, Sharon B.

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 467

Stimulant-Related Reductions of Growth Rates in the PATS

SWANSON, J., GREENHILL, L., WIGAL, T., KOLLINS, S., STEHLI, A., DAVIES, M., CHUANG, S., VITIELLO, B., SKROBALA, A., POSNER, K., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 264

Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: Proof-of-Concept and Proof-of-Product Studies

Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., & Wigal, S. (2003) · Archives of General Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 248

Safety and tolerability of methylphenidate in preschool children with ADHD

WIGAL, T., GREENHILL, L., CHUANG, S., McGOUGH, J., VITIELLO, B., SKROBALA, A., SWANSON, J., WIGAL, S., ABIKOFF, H., KOLLINS, S., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 242

A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)

Swanson, J. M., Wigal, S. B., Wigal, T., Sonuga-Barke, E., Greenhill, L. L., Biederman, J., Kollins, S., Nguyen, A. S., DeCory, H. H., Hirshe Dirksen, S. J., et al. (2004) · Pediatrics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 238

Analog Classroom Assessment of Adderall® in Children With ADHD

SWANSON, J. M., WIGAL, S., GREENHILL, L. L., BROWNE, R., WASLIK, B., LERNER, M., WILLIAMS, L., FLYNN, D., AGLER, D., CROWLEY, K., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 218

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*

Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S. (1999) · Clinical Pharmacology & Therapeutics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 216

The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-Year Follow-Up

Riddle, M. A., Yershova, K., Lazzaretto, D., Paykina, N., Yenokyan, G., Greenhill, L., Abikoff, H., Vitiello, B., Wigal, T., McCracken, J. T., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 202

Pharmacogenetics of Methylphenidate Response in Preschoolers With ADHD

McGOUGH, J., McCRACKEN, J., SWANSON, J., RIDDLE, M., KOLLINS, S., GREENHILL, L., ABIKOFF, H., DAVIES, M., CHUANG, S., WIGAL, T., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 126

Methylphenidate Effects on Functional Outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)

Abikoff, H. B., Vitiello, B., Riddle, M. A., Cunningham, C., Greenhill, L. L., Swanson, J. M., Chuang, S. Z., Davies, M., Kastelic, E., Wigal, S. B., et al. (2007) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 118

Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, SLI381 (ADDERALL XR), in Children With ADHD

MCCRACKEN, J. T., BIEDERMAN, J., GREENHILL, L. L., SWANSON, J. M., MCGOUGH, J. J., SPENCER, T. J., POSNER, K., WIGAL, S., PATAKI, C., ZHANG, Y., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 116

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

the 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health

Attention Deficit Hyperactivity DisorderPharmacology and Obesity Treatment

Cited by 110

A Randomized, Double-Blind, Placebo-Controlled, Laboratory Classroom Assessment of Methylphenidate Transdermal System in Children With ADHD

McGough, J. J., Wigal, S. B., Abikoff, H., Turnbow, J. M., Posner, K., & Moon, E. (2006) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 103

A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity Disorder

WIGAL, S., SWANSON, J. M., FEIFEL, D., SANGAL, R. B., ELIA, J., CASAT, C. D., ZELDIS, J. B., & CONNERS, C. K. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 101

Efficacy and Safety of Ritalin?? LA???, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

Biederman, J., Quinn, D., Weiss, M., Markabi, S., Weidenman, M., Edson, K., Karlsson, G., Pohlmann, H., & Wigal, S. (2003) · Pediatric Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 95

Exercise: Applications to Childhood ADHD

Wigal, S. B., Emmerson, N., Gehricke, J.-G., & Galassetti, P. (2013) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderPhysical Activity and Health

Cited by 93

Catecholamine response to exercise in children with attention deficit hyperactivity disorder.

Wigal, S. B., Nemet, D., Swanson, J. M., Regino, R., Trampush, J., Ziegler, M. G., & Cooper, D. M. (2003) · Pediatric Research

Attention Deficit Hyperactivity DisorderPhysical Activity and Health

Cited by 92

Varying the Wear Time of the Methylphenidate Transdermal System in Children With Attention-Deficit/Hyperactivity Disorder

WILENS, T. E., BOELLNER, S. W., LÓPEZ, F. A., TURNBOW, J. M., WIGAL, S. B., CHILDRESS, A. C., ABIKOFF, H. B., & MANOS, M. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 58

Atomoxetine Improved Attention in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Dyslexia in a 16 Week, Acute, Randomized, Double-Blind Trial

Wietecha, L., Williams, D., Shaywitz, S., Shaywitz, B., Hooper, S. R., Wigal, S. B., Dunn, D., & McBurnett, K. (2013) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 58

Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder

Kollins, S. H., López, F. A., Vince, B. D., Turnbow, J. M., Farrand, K., Lyne, A., Wigal, S. B., & Roth, T. (2011) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 53

Metabolic, toxicological, and safety considerations for drugs used to treat ADHD

Duong, S., Chung, K., & Wigal, S. B. (2012) · Expert Opinion on Drug Metabolism & Toxicology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 42

Adverse Events in Medication Treatment-Naïve Children with Attention-Deficit/Hyperactivity Disorder: Results from a Small, Controlled Trial of Lisdexamfetamine Dimesylate

Wigal, S. B., Wong, A. A., Jun, A., Stehli, A., Steinberg-Epstein, R., & Lerner, M. A. (2012) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 26

Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day

Wigal, S. B., Kollins, S. H., Childress, A. C., & Adeyi, B. (2010) · Child and Adolescent Psychiatry and Mental Health

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 23

Reading Performance as a Function of Treatment With Lisdexamfetamine Dimesylate in Elementary School Children Diagnosed With ADHD

Wigal, S. B., Maltas, S., Crinella, F., Stehli, A., Steinhoff, K., Lakes, K., & Schuck, S. (2012) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 14